QINGSONG HEALTH (02661) announced its allocation results, with a global offering of approximately 26.54 million shares. The Hong Kong public offering accounted for 10% of the total, while the international offering made up the remaining 90%. The final offer price was set at HK$22.68 per share, with net proceeds from the global offering reaching HK$513 million. Each board lot consists of 200 shares, and trading is expected to commence on the Hong Kong Stock Exchange at 9:00 a.m. (Hong Kong Time) on December 23, 2025. The Hong Kong public offering was oversubscribed by 1,421.47 times, while the international offering saw an oversubscription rate of 2.9 times.
Comments